PUBLISHER: The Business Research Company | PRODUCT CODE: 1949668
PUBLISHER: The Business Research Company | PRODUCT CODE: 1949668
Oncology Precision Medicine Global Market Report 2026
Oncology precision medicine is a personalized approach to cancer care that utilizes genetic, molecular, and clinical information to tailor treatment strategies to the specific characteristics of each patient's tumor. Its goal is to improve outcomes by selecting therapies that precisely target the unique biological features of a patient's cancer, resulting in more effective and less toxic treatments.
The main product types in oncology precision medicine include diagnostics, therapeutics, inhibitor drugs, monoclonal antibodies, cell and gene therapies, and antiviral and antiretroviral drugs. Diagnostics involves identifying diseases or medical conditions through examination, testing, and analysis of symptoms or biological samples. Key technologies include genomics, proteomics, bioinformatics, and others. Biomarker types include genetic, protein, epigenetic, and metabolic biomarkers, among others. Applications cover a range of cancers, including breast, lung, colorectal, prostate, cervical, kidney, liver, bladder cancers, and more. These products are utilized by multiple end users, including hospitals, diagnostic laboratories, research institutions, pharmaceutical companies, and others.
Tariffs have influenced the oncology precision medicine market by increasing costs for imported diagnostic instruments, sequencing equipment, and therapeutic biologics. Segments such as next-generation sequencing assays, CAR-T therapies, and monoclonal antibodies are particularly impacted, with North America, Europe, and Asia-Pacific regions like China and India experiencing significant price adjustments. While tariffs pose supply chain challenges and elevate production costs, they also drive local manufacturing initiatives, domestic innovation, and regional investment in precision medicine infrastructure.
The oncology precision medicine market research report is one of a series of new reports from The Business Research Company that provides oncology precision medicine market statistics, including oncology precision medicine industry global market size, regional shares, competitors with a oncology precision medicine market share, detailed oncology precision medicine market segments, market trends and opportunities, and any further data you may need to thrive in the oncology precision medicine industry. This oncology precision medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The oncology precision medicine market size has grown rapidly in recent years. It will grow from $125.14 billion in 2025 to $141.22 billion in 2026 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to limited availability of genomic testing, reliance on standard chemotherapy protocols, increasing cancer prevalence, early development of molecular diagnostics, adoption of hospital-based oncology research programs.
The oncology precision medicine market size is expected to see rapid growth in the next few years. It will grow to $226.55 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to advancements in CAR-T and gene therapies, growth in targeted kinase and immune checkpoint inhibitors, rising investments in precision oncology research, integration of bioinformatics and AI in clinical decision-making, expansion of biomarker-guided clinical trials. Major trends in the forecast period include rising adoption of personalized cancer therapies, increasing use of companion diagnostics and molecular diagnostics, growth in liquid biopsy and next-generation sequencing assays, expansion of targeted therapeutics and monoclonal antibodies, increasing focus on biomarker-based patient stratification.
The rising prevalence of cancer is expected to drive growth in the oncology precision medicine market in the coming years. Cancer is a condition in which abnormal cells grow uncontrollably and may spread to other parts of the body, disrupting normal physiological functions. Its increasing prevalence is largely attributed to aging populations, as longer lifespans lead to the accumulation of DNA mutations, weakened repair mechanisms, chronic inflammation, reduced immune surveillance, and tissue environments that support tumor growth. Oncology precision medicine addresses cancer by offering personalized treatments tailored to the unique genetic profile of each tumor, enhancing treatment efficacy while minimizing side effects. For example, in February 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that the estimated 20 million new cancer cases in 2022 are projected to rise by 77% to over 35 million cases by 2050. This demonstrates that the increasing prevalence of cancer is fueling the oncology precision medicine market.
Key companies in the oncology precision medicine market are focusing on innovative approaches, such as molecular tumor board initiatives, to enable multidisciplinary collaboration and optimize personalized treatment plans. Molecular tumor boards are teams of experts who analyze complex genetic and molecular data to recommend individualized cancer therapies. For instance, in April 2025, McKesson Corporation, a U.S.-based healthcare services and IT company, launched the Precision Care Companion initiative to support biomarker-driven cancer care. The program combines education, technological enhancements, and operational support for oncology practices, bringing together physicians, clinical staff, business leaders, and pharmaceutical partners to integrate advanced genomic testing and targeted therapies more efficiently, thereby improving patient outcomes.
In February 2024, AbbVie Inc., a U.S.-based biopharmaceutical company, acquired ImmunoGen for $10.1 billion. This acquisition allows AbbVie to strengthen its oncology portfolio and accelerate its presence in the solid tumor segment by leveraging ImmunoGen's commercial infrastructure, global reach, and antibody-drug conjugate pipeline beyond ovarian cancer. ImmunoGen Inc., a U.S.-based biotechnology firm, develops antibody-drug conjugates that deliver precision-targeted cancer therapies based on specific tumor biomarkers.
Major companies operating in the oncology precision medicine market are Roche Holding AG, Bristol Myers Squibb Company, Abbott Laboratories, Novartis AG, Gilead Sciences Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., bioMerieux S.A., Bio-Rad Laboratories Inc., Exact Sciences Corporation, Almac Group Limited, OPKO Health Inc., Natera Inc., Myriad Genetics Inc., Pacific Biosciences of California Inc., Asuragen Inc., BGI Group, ANGLE plc.
North America was the largest region in the oncology precision medicine market in 2025. The regions covered in the oncology precision medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the oncology precision medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The oncology precision medicine market consists of revenues earned by entities by providing services such as personalized treatment planning, molecular tumor profiling services, companion diagnostics services, clinical decision support services, and patient risk assessment and stratification. The market value includes the value of related goods sold by the service provider or included within the service offering. The oncology precision medicine market also includes sales of next-generation sequencing (NGS) machines, polymerase chain reaction (PCR) systems, flow cytometers, and robotic sample preparation systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Oncology Precision Medicine Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses oncology precision medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for oncology precision medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The oncology precision medicine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
- Markets Covered:1) By Product Type: Diagnostics; Therapeutics; Inhibitor Drugs; Monoclonal Antibodies; Cell And Gene Therapy; Antiviral And Anti-Retroviral Drugs
- 2) By Technology: Genomics; Proteomics; Bioinformatics; Other Technologies
- 3) By Biomarker Types: Genetic Biomarkers; Protein Biomarkers; Epigenetic Biomarkers; Metabolic Biomarkers; Other Biomarker Types
- 4) By Applications: Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Cervical Cancer; Kidney Cancer; Liver Cancer; Bladder Cancer; Other Applications
- 5) By End-Users: Hospitals; Diagnostic Laboratories; Research Institutions; Pharmaceutical Companies; Other End-Users
- Subsegments:
- 1) By Diagnostics: Companion Diagnostics; Molecular Diagnostics; Liquid Biopsy; Imaging Diagnostics; Next-Generation Sequencing Assays
- 2) By Therapeutics: Tyrosine Kinase Inhibitors (TKIs); Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors); Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors); B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors); Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)
- 3) By Inhibitor Drugs: Tyrosine Kinase Inhibitors (TKIs); Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors); Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors); B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors); Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)
- 4) By Monoclonal Antibodies: Naked Monoclonal Antibodies; Conjugated Monoclonal Antibodies; Bispecific Antibodies; Immune Checkpoint Inhibitors; Radiolabeled Antibodies
- 5) By Cell And Gene Therapy: CAR-T Cell Therapies; T-Cell Receptor (TCR) Therapies; Tumor-Infiltrating Lymphocyte (TIL) Therapies; Oncolytic Viral Therapies; Gene Editing And Replacement Therapies
- 6) By Antiviral And Anti-Retroviral Drugs: Reverse Transcriptase Inhibitors; Protease Inhibitors; Integrase Strand Transfer Inhibitors; Entry Inhibitors; Antiviral Agents Targeting Virus-Related Cancers
- Companies Mentioned: Roche Holding AG; Bristol Myers Squibb Company; Abbott Laboratories; Novartis AG; Gilead Sciences Inc.; Laboratory Corporation of America Holdings; Quest Diagnostics Inc.; Agilent Technologies Inc.; Illumina Inc.; bioMerieux S.A.; Bio-Rad Laboratories Inc.; Exact Sciences Corporation; Almac Group Limited; OPKO Health Inc.; Natera Inc.; Myriad Genetics Inc.; Pacific Biosciences of California Inc.; Asuragen Inc.; BGI Group; ANGLE plc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: Word, PDF or Interactive Report
- + Excel Dashboard
- Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
Table of Contents
1. Executive Summary
- 1.1. Key Market Insights (2020-2035)
- 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
- 1.3. Major Factors Driving the Market
- 1.4. Top Three Trends Shaping the Market
2. Oncology Precision Medicine Market Characteristics
- 2.1. Market Definition & Scope
- 2.2. Market Segmentations
- 2.3. Overview of Key Products and Services
- 2.4. Global Oncology Precision Medicine Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
- Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
- 2.4.4. Market Attractiveness Scoring and Interpretation
- 2.4.5. Strategic Implications and Recommendations
3. Oncology Precision Medicine Market Supply Chain Analysis
- 3.1. Overview of the Supply Chain and Ecosystem
- 3.2. List Of Key Raw Materials, Resources & Suppliers
- 3.3. List Of Major Distributors and Channel Partners
- 3.4. List Of Major End Users
4. Global Oncology Precision Medicine Market Trends And Strategies
- 4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Artificial Intelligence & Autonomous Intelligence
- 4.1.4 Industry 4.0 & Intelligent Manufacturing
- 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
- 4.2. Major Trends
- 4.2.1 Rising Adoption Of Personalized Cancer Therapies
- 4.2.2 Increasing Use Of Companion Diagnostics And Molecular Diagnostics
- 4.2.3 Growth In Liquid Biopsy And Next-Generation Sequencing Assays
- 4.2.4 Expansion Of Targeted Therapeutics And Monoclonal Antibodies
- 4.2.5 Increasing Focus On Biomarker-Based Patient Stratification
5. Oncology Precision Medicine Market Analysis Of End Use Industries
- 5.1 Hospitals
- 5.2 Diagnostic Laboratories
- 5.3 Research Institutions
- 5.4 Pharmaceutical Companies
- 5.5 Cancer Treatment Centers
6. Oncology Precision Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Oncology Precision Medicine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
- 7.1. Global Oncology Precision Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 7.2. Global Oncology Precision Medicine Market Size, Comparisons And Growth Rate Analysis
- 7.3. Global Oncology Precision Medicine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
- 7.4. Global Oncology Precision Medicine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Oncology Precision Medicine Total Addressable Market (TAM) Analysis for the Market
- 8.1. Definition and Scope of Total Addressable Market (TAM)
- 8.2. Methodology and Assumptions
- 8.3. Global Total Addressable Market (TAM) Estimation
- 8.4. TAM vs. Current Market Size Analysis
- 8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Oncology Precision Medicine Market Segmentation
- 9.1. Global Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Diagnostics, Therapeutics, Inhibitor Drugs, Monoclonal Antibodies, Cell And Gene Therapy, Antiviral And Anti-Retroviral Drugs
- 9.2. Global Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Genomics, Proteomics, Bioinformatics, Other Technologies
- 9.3. Global Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Genetic Biomarkers, Protein Biomarkers, Epigenetic Biomarkers, Metabolic Biomarkers, Other Biomarker Types
- 9.4. Global Oncology Precision Medicine Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Bladder Cancer, Other Applications
- 9.5. Global Oncology Precision Medicine Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Hospitals, Diagnostic Laboratories, Research Institutions, Pharmaceutical Companies, Other End-Users
- 9.6. Global Oncology Precision Medicine Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Companion Diagnostics, Molecular Diagnostics, Liquid Biopsy, Imaging Diagnostics, Next-Generation Sequencing Assays
- 9.7. Global Oncology Precision Medicine Market, Sub-Segmentation Of Therapeutics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Tyrosine Kinase Inhibitors (TKIs), Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors), Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors), B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors), Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)
- 9.8. Global Oncology Precision Medicine Market, Sub-Segmentation Of Inhibitor Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Tyrosine Kinase Inhibitors (TKIs), Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors), Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors), B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors), Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)
- 9.9. Global Oncology Precision Medicine Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors, Radiolabeled Antibodies
- 9.10. Global Oncology Precision Medicine Market, Sub-Segmentation Of Cell And Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- CAR-T Cell Therapies, T-Cell Receptor (TCR) Therapies, Tumor-Infiltrating Lymphocyte (TIL) Therapies, Oncolytic Viral Therapies, Gene Editing And Replacement Therapies
- 9.11. Global Oncology Precision Medicine Market, Sub-Segmentation Of Antiviral And Anti-Retroviral Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Reverse Transcriptase Inhibitors, Protease Inhibitors, Integrase Strand Transfer Inhibitors, Entry Inhibitors, Antiviral Agents Targeting Virus-Related Cancers
10. Oncology Precision Medicine Market Regional And Country Analysis
- 10.1. Global Oncology Precision Medicine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- 10.2. Global Oncology Precision Medicine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Oncology Precision Medicine Market
- 11.1. Asia-Pacific Oncology Precision Medicine Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 11.2. Asia-Pacific Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Oncology Precision Medicine Market
- 12.1. China Oncology Precision Medicine Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 12.2. China Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Oncology Precision Medicine Market
- 13.1. India Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Oncology Precision Medicine Market
- 14.1. Japan Oncology Precision Medicine Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 14.2. Japan Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Oncology Precision Medicine Market
- 15.1. Australia Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Oncology Precision Medicine Market
- 16.1. Indonesia Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Oncology Precision Medicine Market
- 17.1. South Korea Oncology Precision Medicine Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 17.2. South Korea Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Oncology Precision Medicine Market
- 18.1. Taiwan Oncology Precision Medicine Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 18.2. Taiwan Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Oncology Precision Medicine Market
- 19.1. South East Asia Oncology Precision Medicine Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 19.2. South East Asia Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Oncology Precision Medicine Market
- 20.1. Western Europe Oncology Precision Medicine Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 20.2. Western Europe Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Oncology Precision Medicine Market
- 21.1. UK Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Oncology Precision Medicine Market
- 22.1. Germany Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Oncology Precision Medicine Market
- 23.1. France Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Oncology Precision Medicine Market
- 24.1. Italy Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Oncology Precision Medicine Market
- 25.1. Spain Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Oncology Precision Medicine Market
- 26.1. Eastern Europe Oncology Precision Medicine Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 26.2. Eastern Europe Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Oncology Precision Medicine Market
- 27.1. Russia Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Oncology Precision Medicine Market
- 28.1. North America Oncology Precision Medicine Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 28.2. North America Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Oncology Precision Medicine Market
- 29.1. USA Oncology Precision Medicine Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 29.2. USA Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Oncology Precision Medicine Market
- 30.1. Canada Oncology Precision Medicine Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 30.2. Canada Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Oncology Precision Medicine Market
- 31.1. South America Oncology Precision Medicine Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 31.2. South America Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Oncology Precision Medicine Market
- 32.1. Brazil Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Oncology Precision Medicine Market
- 33.1. Middle East Oncology Precision Medicine Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 33.2. Middle East Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Oncology Precision Medicine Market
- 34.1. Africa Oncology Precision Medicine Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 34.2. Africa Oncology Precision Medicine Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Biomarker Types, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Oncology Precision Medicine Market Regulatory and Investment Landscape
36. Oncology Precision Medicine Market Competitive Landscape And Company Profiles
- 36.1. Oncology Precision Medicine Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
- 36.2. Oncology Precision Medicine Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
- 36.3. Oncology Precision Medicine Market Company Profiles
- 36.3.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
37. Oncology Precision Medicine Market Other Major And Innovative Companies
- Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., bioMerieux S.A., Bio-Rad Laboratories Inc., Exact Sciences Corporation, Almac Group Limited, OPKO Health Inc., Natera Inc., Myriad Genetics Inc., Pacific Biosciences of California Inc., Asuragen Inc., BGI Group, ANGLE plc
38. Global Oncology Precision Medicine Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Oncology Precision Medicine Market
40. Oncology Precision Medicine Market High Potential Countries, Segments and Strategies
- 40.1 Oncology Precision Medicine Market In 2030 - Countries Offering Most New Opportunities
- 40.2 Oncology Precision Medicine Market In 2030 - Segments Offering Most New Opportunities
- 40.3 Oncology Precision Medicine Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies
41. Appendix
- 41.1. Abbreviations
- 41.2. Currencies
- 41.3. Historic And Forecast Inflation Rates
- 41.4. Research Inquiries
- 41.5. The Business Research Company
- 41.6. Copyright And Disclaimer
